Thapsigargin operates by disrupting calcium homeostasis, leading to a rise in intracellular calcium levels that may activate calcium-dependent kinases capable of modifying the interaction landscape of TEX2. Phosphatidylinositol 3-kinase (PI3K) inhibitors like LY294002 and Wortmannin can cause a reduction in AKT phosphorylation, triggering a cascade of signaling events that may alter TEX2's regulatory mechanisms. U0126, SB 203580, and PD98059, which target different kinases within the MAPK signaling pathways, may influence TEX2 by changing the phosphorylation dynamics of proteins that interact with or regulate TEX2.
Rapamycin inhibits the mTOR pathway, which could lead to alterations in cellular processes that affect TEX2's activity. Dibutyryl-cAMP, a synthetic analog of cAMP, bypasses cellular receptors and directly stimulates cAMP-dependent pathways, which could impact TEX2 through PKA-mediated effects. Ionomycin, by raising intracellular calcium, might act on calcium-sensitive proteins that engage with TEX2. The activation of the Wnt signaling pathway, triggered by compounds like Wnt Agonist, may influence TEX2 through its downstream gene transcription effects. Okadaic Acid's inhibition of protein phosphatases PP1 and PP2A is known to increase the phosphorylation state of numerous proteins, potentially affecting those that regulate the activity of TEX2.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump leading to increased cytosolic calcium, which may activate calcium-dependent kinases that phosphorylate TEX2 or its regulators. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which may lead to reduced phosphorylation of AKT and alter TEX2 activity through downstream effects on signaling pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2 in the ERK signaling pathway, which may alter the phosphorylation state of TEX2 activity regulators. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which may affect TEX2 activity by modulating stress-related signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may lead to decreased ERK activation and influence TEX2 activity by altering its phosphorylation state. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which may modulate TEX2 activity through effects on cell growth and metabolism-related pathways. | ||||||
Wnt Agonist | 853220-52-7 | sc-222416 sc-222416A | 5 mg 25 mg | $157.00 $609.00 | 23 | |
Activates the Wnt signaling pathway, which may influence TEX2 activity through regulation of gene transcription. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that may activate cAMP-dependent pathways, potentially affecting TEX2 activity via PKA-mediated phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which may activate calcium-dependent proteins that interact with TEX2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, which may lead to increased phosphorylation of proteins regulating TEX2 activity. | ||||||